Dipeptidyl-peptidase 4 Inhibition: Linking Metabolic Control to Cardiovascular Protection

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|20|14|2387-2394

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.20, Iss.14, 2014-04, pp. : 2387-2394

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dipeptidyl Peptidase-4 Inhibition: Linking Chemical Properties to Clinical Safety

By  

Current Medicinal Chemistry, Vol. 18, Iss. 31, 2011-11 ,pp. : 4753-4760

Bentham Science Publishers

Access to resources Recommend Favorite

Medicinal Chemistry Approaches to the Inhibition of Dipeptidyl Peptidase IV

By  

Current Topics in Medicinal Chemistry, Vol. 8, Iss. 17, 2008-01 ,pp. : 1545-1552

Bentham Science Publishers

Access to resources Recommend Favorite

The dipeptidyl peptidase-4 inhibitor alogliptin improves glycemic control in type 2 diabetic patients undergoing hemodialysis

By Fujii Yuki   Abe Masanori   Higuchi Terumi   Mizuno Mari   Suzuki Hiroko   Matsumoto Shiro   Ito Midori   Maruyama Noriaki   Okada Kazuyoshi   Soma Masayoshi  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 3, 2013-02 ,pp. : 259-267

Informa Healthcare

Access to resources Recommend Favorite

Emerging dipeptidyl peptidase-4 inhibitors for the treatment of diabetes

By Ahrén Bo  

Expert Opinion on Emerging Drugs, Vol. 13, Iss. 4, 2008-12 ,pp. : 593-607

Informa Healthcare

Access to resources Recommend Favorite

Pharmacology of Dipeptidyl Peptidase-4 Inhibitors: Similarities and Differences

By Baetta Roberta   Corsini Alberto  

Drugs, Vol. 71, Iss. 11, 2011-07 ,pp. : 1441-1467

Adis International

Access to resources Recommend Favorite